|
[1]
|
Assesing Conversion Rate, Treatment Success and Mortality of Drug Induce Liver Injury from First Line Antituberculosis Regiment: A Systematic Review and Meta -Analysis
F1000Research,
2025
DOI:10.12688/f1000research.161606.1
|
|
|
|
|
[2]
|
Artificial intelligence as a promising tool for predicting drug-induced liver injury in patients receiving tuberculosis medication: A systematic review
Digital Medicine,
2025
DOI:10.1097/DM-2025-00006
|
|
|
|
|
[3]
|
Antituberculosis drug-induced hepatotoxicity: Preclinical benefit of glutamine
Eurasian Journal of Toxicology,
2024
DOI:10.51262/ejtox.1554123
|
|
|
|
|
[4]
|
A Concise Review on Incidence and Risk Factors for Antituberculous Treatment-induced Hepatotoxicity
Annals of SBV,
2019
DOI:10.5005/jp-journals-10085-8108
|
|
|
|
|
[5]
|
A Severe Autoimmune-like Anti-Tuberculosis Drug-induced Liver Injury: Case Report and Review
Journal of Microbiology and Infectious Diseases,
2018
DOI:10.5799/jmid.458463
|
|
|
|
|
[6]
|
THE RISK FACTORS FOR DRUG INDUCED HEPATITIS IN PULMONARY TUBERCULOSIS PATIENTS IN DR. SOETOMO HOSPITAL
Indonesian Journal of Tropical and Infectious Disease,
2018
DOI:10.20473/ijtid.v7i3.8689
|
|
|
|